“Modest” Survival Gains Seen for De Novo Metastatic Cancers in Last 30 Years
Patients with de novo metastatic cancer have seen modest improvements in survival over the last 3 decades, according to researchers.
Diagnosis & Disease Information
Retevmo Approved for RET-Driven Solid Tumors, NSCLC
The approvals were based on data from the LIBRETTO-001 trial.
Large Disparities in End-of-Life Care Observed Between Solid Tumors and Hematologic Malignancies
An analysis of data from SEER-Medicare database compared end-of-life care, including hospitalizations and use of hospice, between patients with solid tumors and hematologic malignancies.
ESMO Issues Recommendations on Use of Multigene NGS in Metastatic Solid Tumor Profiling
These are the first set of recommendations on the use of tumor multigene NGS profiling in daily practice issued by a scientific society for patients with metastatic cancer.
Test of Vascular Function May Predict Solid-Tumor Cancer Risk
Reactive hyperemia peripheral arterial tonometry index ≤2.0 predicted incidence of solid-tumor cancer.
Standardization Could Improve Tumor Board Interpretation, Recommendations
Using fictional patient profiles and a questionnaire on recommendation procedures, researchers were able to demonstrate a need for standardized tumor board interpretation and recommendation processes worldwide.
Does a Diagnosis of Solid Tumor Prohibit Postsurgical ICU Admissions?
Using a comparator group, researchers sought to determine the impact of a diagnosis of solid tumor on outcomes among postsurgical ICU admissions in patients with cancer vs those without cancer.
Durable Tumor Response Seen in Some Lymphomas With Tazemetostat
Tazemetostat demonstrated preclinical activity against EZH2-mutant non-Hodgkin lymphomas.
Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
[Breast Cancer: Targets and Therapy] A review of studies investigating the efficacy of buparlisib monotherapy and in combination with various other anticancer agents in the treatment of breast cancer and other solid tumors.
Statins, Antihypercholesterolemic Drugs Show Potential as Anticancer Agents
Study results demonstrate that statins have antitumor activity in various solid-tumor cancers and leukemia; however, experts offer these caveats on using them to treat cancer — at least for now.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...